Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease
- PMID: 2907524
- DOI: 10.1007/BF03350193
Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease
Abstract
The temporal relationship between the onset of Graves' ophthalmopathy and the onset of thyroidal Graves' disease was evaluated in 125 consecutive patients with Graves' ophthalmopathy. Thyroidal Graves' disease--past or present--was clinically evident in 99 patients (79%): hyperthyroidism in 3 cases. Thyroid disease preceded the eye disease in 37 patients, it occurred simultaneously with the eye disease in 39 patients, and it developed after the eye disease in 23 patients (in 16 cases within one yr after the onset of eye disease). The age at the onset of thyroid disease (38.7 +/- 12.9 yr) was lower than the age at the onset of ophthalmopathy (41.8 +/- 12.5 yr; p less than 0.001). Among the 26 clinically euthyroid patients (21%) laboratory evidence of thyroidal Graves' disease was found in 14 cases (11%): abnormal TRH test, n = 9; normal TRH test but abnormal T3-suppression test, n = 4; normal TRH and T3-suppression tests but positive thyroid stimulating antibodies, n = 1). We conclude that Graves' ophthalmopathy as a rule develops at a time when thyroid autoimmunity also exists. This strongly suggests a common factor in the pathogenesis of thyroidal and ocular expressions of Graves' disease.
Similar articles
-
Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.Endocr J. 1995 Jun;42(3):405-12. doi: 10.1507/endocrj.42.405. Endocr J. 1995. PMID: 7670570
-
Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.Thyroid. 1998 Oct;8(10):881-5. doi: 10.1089/thy.1998.8.881. Thyroid. 1998. PMID: 9827654
-
Thyrotropin receptor antibodies in hypothyroid Graves' disease.J Clin Endocrinol Metab. 1993 Feb;76(2):504-8. doi: 10.1210/jcem.76.2.8094394. J Clin Endocrinol Metab. 1993. PMID: 8094394
-
Graves' ophthalmopathy.Can Med Assoc J. 1981 Apr 1;124(7):855-62, 866. Can Med Assoc J. 1981. PMID: 7011529 Free PMC article. Review.
-
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?J Endocrinol Invest. 2008 Jun;31(6):578-81. doi: 10.1007/BF03346411. J Endocrinol Invest. 2008. PMID: 18591894 Review. No abstract available.
Cited by
-
Thyroid Eye Disease: Navigating the New Treatment Landscape.J Endocr Soc. 2021 Mar 17;5(5):bvab034. doi: 10.1210/jendso/bvab034. eCollection 2021 May 1. J Endocr Soc. 2021. PMID: 33948524 Free PMC article.
-
Thyroid Eye Disease.Curr Treat Options Neurol. 2000 Sep;2(5):401-406. doi: 10.1007/s11940-000-0038-6. Curr Treat Options Neurol. 2000. PMID: 11096765
-
Emergency Endoscopic Endonasal Optic Nerve Decompression for Graves' Orbitopathy.Cureus. 2024 Sep 1;16(9):e68384. doi: 10.7759/cureus.68384. eCollection 2024 Sep. Cureus. 2024. PMID: 39355489 Free PMC article.
-
Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.Int Ophthalmol. 1990 Jan;14(1):25-30. doi: 10.1007/BF00131165. Int Ophthalmol. 1990. PMID: 2182563 Review.
-
Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.J Clin Endocrinol Metab. 2024 Jan 18;109(2):516-526. doi: 10.1210/clinem/dgad501. J Clin Endocrinol Metab. 2024. PMID: 37622279 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous